Literature DB >> 21765444

Cholera toxin inhibits human hepatocarcinoma cell proliferation in vitro via suppressing ATX/LPA axis.

Qi Xia1, An-mei Deng, Shan-shan Wu, Min Zheng.   

Abstract

AIM: To investigate the antitumor effect of cholera toxin (CT) in hepatocellular carcinoma (HCC) in vitro and the mechanisms underlying the effect.
METHODS: Human hepatocellular carcinoma cell lines Hep3B and Huh7, which expressed moderate and high level of autotaxin (ATX), respectively, were used. Cytokine level in the cells was evaluated using ELISA assay, and cell proliferation was investigated using MTT assay. ATX expression was determined using Western blot. ATX/lyso-PLD activity in the conditioned medium was measured using FS-3, a fluorescent lysophosphatidylcholine (LPC) analogue, as substrate.
RESULTS: Exposure to CT (7.5 and 10 ng/mL) significantly inhibited the cell growth, decreased secretion of proinflammatory cytokine TNF-α and promoted secretion of anti-inflammatory cytokines IL-4 and IL-10. CT at 10 ng/mL markedly suppressed ATX expression in Hep3B and Huh7 cells. Furthermore, ATX and lysophosphatidic acid (LPA) were found to be crucial for growth of the cancer cells. CT could inhibit TNF-α-induced expression and secretion of ATX that led to decreased activity of lysophospholipase D, thus decreasing the conversion of LPC to LPA.
CONCLUSION: CT inhibits hepatocellular carcinoma cell growth in vitro via regulating the ATX-LPA pathway.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21765444      PMCID: PMC4002524          DOI: 10.1038/aps.2011.31

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  27 in total

1.  Autotaxin is overexpressed in glioblastoma multiforme and contributes to cell motility of glioblastoma by converting lysophosphatidylcholine to lysophosphatidic acid.

Authors:  Yasuhiro Kishi; Shinichi Okudaira; Masayuki Tanaka; Kotaro Hama; Dai Shida; Joji Kitayama; Takao Yamori; Junken Aoki; Takamitsu Fujimaki; Hiroyuki Arai
Journal:  J Biol Chem       Date:  2006-04-19       Impact factor: 5.157

2.  Role of platelet activating factor in the intestinal epithelial secretory and Chinese hamster ovary cell cytoskeletal responses to cholera toxin.

Authors:  R L Guerrant; G D Fang; N M Thielman; M C Fonteles
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-27       Impact factor: 11.205

3.  Global cancer statistics, 2002.

Authors:  D Max Parkin; Freddie Bray; J Ferlay; Paola Pisani
Journal:  CA Cancer J Clin       Date:  2005 Mar-Apr       Impact factor: 508.702

Review 4.  Hepatic tumor necrosis factor signaling and nuclear factor-kappaB: effects on liver homeostasis and beyond.

Authors:  Andy Wullaert; Geert van Loo; Karen Heyninck; Rudi Beyaert
Journal:  Endocr Rev       Date:  2007-04-12       Impact factor: 19.871

5.  Arrest of hormone-dependent mammary cancer growth in vivo and in vitro by cholera toxin.

Authors:  Y S Cho-Chung; T Clair; C Shepheard; B Berghoffer
Journal:  Cancer Res       Date:  1983-04       Impact factor: 12.701

6.  Identification, purification, and partial sequence analysis of autotaxin, a novel motility-stimulating protein.

Authors:  M L Stracke; H C Krutzsch; E J Unsworth; A Arestad; V Cioce; E Schiffmann; L A Liotta
Journal:  J Biol Chem       Date:  1992-02-05       Impact factor: 5.157

7.  Stimulation of tumor cell motility linked to phosphodiesterase catalytic site of autotaxin.

Authors:  H Y Lee; T Clair; P T Mulvaney; E C Woodhouse; S Aznavoorian; L A Liotta; M L Stracke
Journal:  J Biol Chem       Date:  1996-10-04       Impact factor: 5.157

8.  Microarray analysis identifies Autotaxin, a tumour cell motility and angiogenic factor with lysophospholipase D activity, as a specific target of cell transformation by v-Jun.

Authors:  Elizabeth J Black; Timothy Clair; Jeffrey Delrow; Paul Neiman; David A F Gillespie
Journal:  Oncogene       Date:  2004-03-25       Impact factor: 9.867

9.  Plasma lysophosphatidylcholine levels: potential biomarkers for colorectal cancer.

Authors:  Zhenwen Zhao; Yijin Xiao; Paul Elson; Haiyan Tan; Sarah J Plummer; Michael Berk; Phyu P Aung; Ian C Lavery; Jean P Achkar; Li Li; Graham Casey; Yan Xu
Journal:  J Clin Oncol       Date:  2007-07-01       Impact factor: 44.544

Review 10.  Infectious diarrhea.

Authors:  L Goodman; J Segreti
Journal:  Dis Mon       Date:  1999-07       Impact factor: 3.800

View more
  5 in total

Review 1.  Autotaxin, a lysophospholipase D with pleomorphic effects in oncogenesis and cancer progression.

Authors:  Lorenzo Federico; Kang Jin Jeong; Christopher P Vellano; Gordon B Mills
Journal:  J Lipid Res       Date:  2015-05-14       Impact factor: 5.922

2.  Regulation of autotaxin expression and secretion by lysophosphatidate and sphingosine 1-phosphate.

Authors:  Matthew G K Benesch; Yuan Y Zhao; Jonathan M Curtis; Todd P W McMullen; David N Brindley
Journal:  J Lipid Res       Date:  2015-04-20       Impact factor: 5.922

3.  Association between post-diagnostic use of cholera vaccine and risk of death in prostate cancer patients.

Authors:  Jianguang Ji; Jan Sundquist; Kristina Sundquist
Journal:  Nat Commun       Date:  2018-06-18       Impact factor: 14.919

4.  Serum ATX as a novel biomarker for breast cancer.

Authors:  Yingbo Shao; Yang Yu; Yaning He; Qi Chen; Hui Liu
Journal:  Medicine (Baltimore)       Date:  2019-03       Impact factor: 1.889

Review 5.  KAI1/CD82 gene and autotaxin-lysophosphatidic acid axis in gastrointestinal cancers.

Authors:  Shuo Wang; Jiang Chen; Xiao-Zhong Guo
Journal:  World J Gastrointest Oncol       Date:  2022-08-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.